Empros Pharma

Empros Pharma is a drug development company active in the field of metabolic and cardiovascular diseases.

Empros Pharma develops pharmaceutical treatment against overweight and obesity. The EMP16 product is now in efficacy proof-of-concept clinical trials. The early phase safety and tolerability trials are finalized, demonstrating a best-in-class safety profile and improved blood glucose control.